ASTHMA MORTALITY
Asthma is often considered a chronic but not a life-threatening disease, a view perhaps born of comments made by the distinguished Sir. William Osler at the beginning of the last century, when he referred to the "asthmatic panting into old age" (1) . The World Health Organization (WHO), however, estimate that asthma accounts for 1 in every 250 deaths worldwide (2) . The Global Burden of Asthma Report (3) , developed for the Global Initiative for Asthma in 2004, compiled WHO country-specific asthma mortality rates in the 5-to 34-year age group (the diagnosis of asthma mortality is firmly established in this group). China, Russia, South Africa, and Mexico record some of the highest asthma case fatalities in the world, with more than 10 out of 100,000 individuals with asthma dying each year as a result of their asthma.
There is no doubt that recent advances in the understanding of the pathophysiology of asthma, the development and use of effective treatment targeting airway inflammation, and improvements in asthma education and self management has resulted in a decrease in asthma mortality. Recent large epidemiologic studies have demonstrated that regular treatment with conventional or low-dose inhaled corticosteroids results in a significant reduction in fatalities due to asthma (4, 5) . After the introduction of Pranlukast (leukotriene receptor antagonist) to the Japanese (Received in original form February 12, 2005 ; accepted in final form May 6, 2005) Correspondence and requests for reprints should be addressed to Siobhán O' Sulli- van (6) .
While acknowledging the contribution of effective treatment to decreasing asthma mortality, it is worth noting that the annual rate of asthma-related deaths in the United States increased from 1.3 to 1.9 per 100,000 during the 10-year period from 1980 to 1990 (7) . Since 1988, rates of death from asthma in the United States for most ages have stabilized, but at rates more than 50% higher than those of 1979 (8, 9) .
PATHOLOGY OF ASTHMA DEATH
Much of what we know today about the inflammatory basis of asthma is as a result of insights gained from the histopathologic and immunopathologic examination of bronchi from patients who have died of asthma. The cardinal features of asthma death pathology include loss of the airway epithelium, increased thickening of the reticular membrane, occlusion of the airways by plugs of mucus, and infiltration of inflammatory cells, specifically neutrophils and eosinophils into the airway wall (10, 11) . It has been proposed that asthma deaths can be differentiated according to the time between onset of acute attack and the time of death (11). Sur and coworkers observed that eosinophils were more abundant in cases of slow-onset than sudden-onset fatal asthma, whereas neutrophils were mainly associated with sudden-onset fatal asthma. In the view of the this author, the stimulus rather than the time-frame between the attack and death is crucial in determining the pathologic picture in terms of inflammatory cells. In virally induced severe asthma exacerbations, an intense sputum neutrophil influx and degranulation as been documented. In contrast, severe asthma exacerbations due to noninfective causes are characterized by increased eosinophil activation and interleukin (IL)-5 in sputum (12) .
VIRUSES AS A PRECIPITATING FACTOR IN ASTHMA DEATH
There is surprisingly little data available in relation to precipitating factors in asthma death. The stimuli most often associated in the literature with asthma death are profound emotional upsets, ingestion of nonsteroidal antiinflammatory drugs, air pollution, thermal inversions, and seasonal or perennial exposure to allergens (13, 14) .
In the last number of years, a substantial body of evidence has accumulated implicating viruses as an important precipitating factor for asthma exacerbations. Johnston and colleagues reported that 80 to 85% of childhood asthma exacerbations are associated with viral airway infection in children aged 9 to 11 years. Rhinovirus was the most commonly identified virus (15) . In adults the incidence of virus in asthma exacerbations seems to be lower than that reported in children. Nicholson and coworkers in a longitudinal study of adults with asthma documented that 44% of asthma exacerbations in adults were associated with a viral infection (16) . In adults requiring hospital admission for an acute severe asthma exacerbation in a 1-year period, virus was identified in 29% of the subjects, with rhinovirus and influenza A, the most commonly identified infectious agents (17) .
Clearly, viruses are important in precipitating asthma exacerbations, even severe exacerbations, but until quite recently, the Definition of abbreviations: AD ϭ subjects who died from asthma; AUC ϭ subjects with asthma who died from causes unrelated to asthma; C ϭ control subjects without asthma; PCR ϭ polymerase chain reaction.
role of viruses as a precipitating factor in asthma death has remained ambiguous. This has largely been due to the difficulty in gaining access to individuals with asthma during the terminal event, because slightly fewer than half of all deaths occur in a hospital (18) (19) (20) and because of the lack of sensitive methodologies to detect virus in the lower airways.
More recently, using a polymerase chain reaction (PCR)-based method, adenovirus and picornavirus were isolated from respiratory secretions in 10 of 17 patients hospitalized with nearfatal asthma (21) . We have previously documented that viruses are present within the lower respiratory tract in asthma death (22) . Postmortem lung biopsies were obtained from seven victims of asthma death (AD), seven individuals with asthma who died of a cause unrelated to their asthma (AUC), and seven control subjects with no history or evidence of respiratory disease (C). Application of a virus PCR panel designed to detect common respiratory viruses and atypical bacteria to bronchial tissue revealed the presence of rhinovirus (RV) and respiratory syncytial virus (RSV) in the subjects with asthma, but not in the control subjects (Table 1) . There was a similar prevalence of nucleic acid from these viruses among the individuals with asthma who died an asthma death and the individuals with asthma who died of another cause. Moreover, viral load was similar in both groups. We could not find an association of a specific virus or combination of viruses with fatal asthma. Macek and colleagues with the same study design in terms of patient groups, detected virus in postmortem specimens of lower airway secretions in 19 of 20 subjects, and multiple viruses were detected in 14 subjects. In agreement with our study, the prevalence of each virus was similar in the three groups studied and the lower airway secretions did not show a specific pattern of viral nucleic acid (23) . Using reverse transcription PCR, Watson and coworkers did not detect RV in archival, wax-embedded lung tissue obtained postmortem from patients who had died from asthma. The authors suggest that this may have been due to viral RNA degradation occurring between the time of death and when the postmortem material was collected and preserved (24) .
MECHANISMS OF VIRALLY INDUCED ASTHMA EXACERBATIONS
A number of mechanisms have been identified that could contribute to airway obstruction and increased airway responsiveness (AHR) seen in virally induced exacerbations of asthma. Viral infection results in the release of proinflammatory chemokines and cytokines, including IL-6, IL-8, IL-11, and granulocyte colony-stimulating factor (25) (26) (27) . Once these cytokines and chemokines are released, they induce infiltration and activation of inflammatory cells into the airway. Concentrations of IL-8 and RANTES in respiratory secretions of infants with bronchiolitis correlate with the number of leukocytes in the same secretions, indicating that these chemokines may be responsible for leukocyte infiltration of the airway during RSV infection.
Neutrophils are prominent in the airway and the peripheral blood during acute viral infection (28, 25) . Neutrophil counts in the peripheral blood of 35 individuals with atopic asthma inoculated with RV 16, correlated with virally induced changes in AHR (25) . Eosinophils are present in airway mucosal biopsy samples from individuals with asthma during experimental RV 16 infection (29) . Furthermore, Grü nberg and coworkers documented increased sputum eosinophil cationic protein in individuals with asthma after experimental infection with RV 16 (30) . Respiratory viruses also induce early, nonspecific T cell recruitment. Lymphopenia occurs in peripheral blood during the acute phase of rhinoviral infection, suggestive of a lymphocytic migration to the lung (31). Fraenkel and colleagues demonstrated a bronchial mucosal lymphocytic infiltrate in association with RV 16 infection. (29) . Once present in the airways, T lymphocytes may enhance preexisting inflammation by releasing chemotactic cytokines, thereby attracting mast cells, basophils, and eosinophils. Depletion of CD8ϩ T cells in RSV-infected mice results in an inhibition of local IL-5 production in the airways, which is critical for recruitment of eosinophils and development of AHR (32).
CD8ϩ T LYMPHOCYTE RESPONSE TO RESPIRATORY VIRUSES

Viral infections characteristically elicit strong CD8ϩ T-cell lymphocytosis predominated by cytotoxic, IFN-␥-secreting cells (33). Evidence points to both a salubrious and deleterious role for CD8 T cells in the context of respiratory viral infection.
Studies in both mouse models and humans have demonstrated that CD8ϩ cytotoxic T lymphocytes (CTLs) play a crucial role in eradicating virus from the respiratory tract. Influenza virus is initially eliminated via killing of virally infected epithelial cells by MHC class I restricted CD8ϩ CTLs, which are recruited into the airway and peak at 7 days after infection (34) . RSVspecific CTLs are present in peripheral blood of children with acute bronchiolitis, in whom CTL responses are associated with decreased clinical symptoms (35) . In children with adenovirus infection, CD8ϩT cells are increased during the acute phase of the infection comapred with control subjects and return to normal during the convalescent stage (36) .
Studies in murine models have provided evidence that RSVspecific CD8ϩ T cells may play a role in RSV-induced lung pathogenesis. Passive transfer of RSV-specific CTLs to infected mice results in virus clearance, which is associated with acute and sometimes fatal pulmonary disease (37) . Interestingly, clearance of virus by influenza-specific CTLs in the lung of influenza-infected mice correlates with resolution of pulmonary pathology (38) .
ROLE OF CD8ϩ T LYMPHOCYTES IN VIRALLY INDUCED ASTHMA EXACERBTIONS AND ASTHMA DEATH
Analysis of submucosal cell counts before, during, and after experimental RV 16 infection of a group of individuals with asthma and without asthma revealed a significant increase in the number of CD3ϩ T lymphocytes during the cold. There was a subsequent decrease in the numbers of CD3ϩ T lymphocytes observed during the convalescence period. Examination of the CD8ϩ T subset in bronchial biopises from both individuals with and without asthma revealed similar strong trends. However, due to the small sample size, no firm conclusions could be drawn with respect to differences between the numbers of CD8ϩ T Lee and coworkers documented a high percentage of CD8ϩ T cells in the bronchoalveolar lavage from patients with asthma compared with control subjects, resulting in a decreased CD4/ CD8 ratio (39) . In contrast, the CD4/CD8 ratio in the peripheral blood during acute asthma exacerbation was significantly higher than that of control subjects. This would seem to suggest that CD8ϩ T cells are more sequestered in the airway during an acute asthma attack. No attempt however, was made to document the etiology, viral or otherwise, of the acute asthma exacerbations under observation in this study.
Earlier work from our laboratory has demonstrated that T cells represented the major cell type identified in the inflammatory infiltrate in both the proximal and distal airways in five cases of asthma death. Subset analysis revealed that the majority of T cells both in the proximal and distal airways were CD8ϩ T cells (40) . In a subsequent study, postmortem samples from the peribronchial region of the lung were obtained from asthma death cases, individuals with asthma who died of unrelated causes, and postmortem cases with no history of lung disease. An expanded CD8ϩ T cell population dominated by activated (CD25ϩ) CD8ϩ CTLs were observed in the asthma death cases in association with a viral infection (Figure 1) (22) . Unfortunately, viral specificity of the CD8ϩ CTLs was not assessed in this study due to the difficulties in applying major histocompatibility complex class I tetramer technology to tissue.
It is impossible to determine if the CD8ϩ CTL infiltrate observed in the asthma death group was as a result of increased recruitment of CD8ϩ T cells to the airways, or a defect in apoptosis of these cells. One potential mechanism for increased infiltration of CD8ϩ T cells into the asthmatic lung is BLT-1-mediated LTB 4 chemotaxis (41). Tager and colleagues have demonstrated BLT-1-mediated LTB 4 -induced CD8ϩ T cell recruitment into the airway in a murine asthma model (42) . Interestingly, increased levels of the proinflammatory mediator LTB 4 have been documented in endotracheal aspirates from 14 children intubated with RSV bronchiolitis, compared with control subjects (43) , and increases in plasma LTB 4 levels have been described in children during acute asthmatic episodes (44) . As previously mentioned, neutrophils are a prominent feature of the cellular immune response to respiratory viruses and are the predominant cellular source of LTB4.
Apoptosis of expanded virus-specific cytotoxic CD8ϩ T cells limits tissue damage and reestablishes cellular homeostasis after a viral infection (45) . In the aforementioned study (22) , expression of the antiapoptotic protein Bcl-2 was lower in both the asthmatic groups in whom viral RNA was detected, irrespective of whether they had died as a result of their asthma. This would suggest that there was an attempt by the immune system to resolve the viral infection, making a defect in apoptosis an unlikely cause of the bronchial CD8ϩ CLT infiltrate observed.
Coyle and coworkers have demonstrated that a type 2 (Th2) cytokine environment, such as that in the asthmatic lung, can transform CD8ϩ cytotoxic T cells into noncytotoxic IL-5-producing cells in vivo (46) . This IL-4-dependent switch to CD8ϩ T cells that secrete IL-5 is thought to not only promote eosinophilia but also to lead to impaired viral clearance owing to reductions in IFN-␥ production. CD8ϩ T cells from RSV-infected infants produce more IL-4 and less IFN-␥ than those from healthy control subjects (47) . A low IFN-␥/IL-4 ratio has also been documented after mitogen stimulation of peripheral blood mononuclear cells from RSV-infected infants (48) . A significantly higher percentage of IL-4-producing CD8ϩ T cells have been found in postmortem bronchial biopsies from asthma death cases compared with control subjects without asthma (22) . Together, these studies provide evidence for a viral-induced Th1/Th2 "switch" in vivo, thereby providing a potential mechanism for eosinophil recruitment and impaired viral clearance in individuals with asthma.
Undoubtedly, CD8ϩ CTLs are a crucial player in cell-mediated immunity in response to respiratory viruses. However, a fine balance clearly exists between the protective and pathologic effects of these cells. It would appear that a dysregulation or aberrant CD8ϩ T cell responses in the context of a viral infection may place individuals with asthma at risk for fatal asthma.
